792500
ピルビン酸ナトリウム
anhydrous grade, ≥99%, ReagentPlus®, Redi-Dri™, free-flowing, powder
別名:
α-ケトプロピオン酸 ナトリウム塩, 2-オキソプロパン酸 ナトリウム塩, ピルビン酸 ナトリウム塩
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
化学式:
CH3COCOONa
CAS番号:
分子量:
110.04
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
204-024-4
MDL number:
Beilstein/REAXYS Number:
3568341
Assay:
≥99%
Grade:
anhydrous
Form:
powder
Solubility:
H2O: 100 mg/mL, clear, colorless to faintly yellow
製品名
ピルビン酸ナトリウム, anhydrous, free-flowing, Redi-Dri™, ReagentPlus®, ≥99%
grade
anhydrous
Quality Level
product line
Redi-Dri™, ReagentPlus®
assay
≥99%
form
powder
quality
free-flowing
loss
≤0.5% loss on drying
mp
>300 °C (lit.)
solubility
H2O: 100 mg/mL, clear, colorless to faintly yellow
cation traces
heavy metals (as Pb): ≤20 ppm
functional group
ketone
storage temp.
2-8°C
SMILES string
[Na+].CC(=O)C([O-])=O
InChI
1S/C3H4O3.Na/c1-2(4)3(5)6;/h1H3,(H,5,6);/q;+1/p-1
InChI key
DAEPDZWVDSPTHF-UHFFFAOYSA-M
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under ピルビン酸ナトリウム
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Sens. 1B
保管分類
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
資料
Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.
Rekin's Janky et al.
PLoS computational biology, 10(7), e1003731-e1003731 (2014-07-25)
Identifying master regulators of biological processes and mapping their downstream gene networks are key challenges in systems biology. We developed a computational method, called iRegulon, to reverse-engineer the transcriptional regulatory network underlying a co-expressed gene set using cis-regulatory sequence analysis.
Tetsufumi Ito et al.
The Journal of comparative neurology, 523(15), 2277-2296 (2015-04-17)
Large GABAergic (LG) neurons form a distinct cell type in the inferior colliculus (IC), identified by the presence of dense VGLUT2-containing axosomatic terminals. Although some of the axosomatic terminals originate from local and commissural IC neurons, it has been unclear
Philipp Müller et al.
Science translational medicine, 7(315), 315ra188-315ra188 (2015-11-27)
Targeted drug delivery with antibody-drug conjugates such as the HER2-directed ado-trastuzumab emtansine (T-DM1) has emerged as a powerful strategy for cancer therapy. We show that T-DM1 is particularly effective in eliciting antitumor immunity in patients with early breast cancer (WSG-ADAPT